Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ExpreS2ion announces completion of GLP safety study for ES2B-C001 (HER2-VLP) breast cancer vaccine candidate

Hørsholm, Denmark, 16 April 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") is pleased to announce the completion of the final report for the Good Laboratory Practice (GLP) safety study in non-human primates of the ES2B-C001 (HER2-VLP) breast cancer vaccine candidate.This significant milestone marks an important step towards enabling a clinical trial application. The Company is currently focusing on Good Manufacturing Practice (GMP) production and designing the Phase I clinical trial, with the aim to initiate the Phase I trial within the next

BerGenBio ASA: Final results for the last exercise period for warrants issued in connection with rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. Bergen, Norway, 16 April 2024 - Reference is made to the stock exchange announcement published by BerGenBio ASA (the "Company") 2 April 2024 regarding the start of the last exercise period for the warrants (the "Warrants")

TATAA Biocenter Achieves GLP Accreditation for qPCR and dPCR

Approval enables regulated analysis services for cell and gene therapies. This important milestone for TATAA Biocenter provides customers access to safety testing, accelerating the transition of promising therapies from laboratory research and preclinical testing to clinical applications.TATAA Biocenter announced today that it has been awarded Good Laboratory Practice (GLP) accreditation. The accreditation represents a crucial step in the company’s strategic progression into a market leading molecular analysis contract research organization (CRO) expediting biopharmaceutical innovations in

Invitation to presentation of Platzer’s Interim Report for Jan-Mar 2024

Platzer’s Interim Report for the period January-March 2024 will be published on 17 April, at 08.00 CEST.At 10:00 CEST on the same day, investors, analysts, media and other interested parties are invited to a presentation of the report with the opportunity to participate via a webcast teleconference. Johanna Hult Rentsch, CEO, and Fredrik Sjudin, CFO, will present the results for the first quarter of 2024. The presentation will be in Swedish and will be followed by a Q&A session.Date:                 17 April 2024Time:                10.00 CESTDirect link to webcastTo take part in

NOQX secures major investors

The SaaS company NOQX  was founded in May 2023 by Sophie Hedestad, Robert Zetterqvist, and Matilda Lundsten. In a short time, NOQX has become one of the leading SaaS companies in goal management and OKRs , with a clear focus on making goal management enjoyable and successful for employees. Today, NOQX announces that they have successfully secured their first round of funding from an impressive group of investors. Of note is Phillip Chambers, founder Peakon, which sold to Workday for $700 million USD in 2021. Chambers comments: "I connected

Invitation to presentation of Nordic Paper’s interim report Q1 2024

Nordic Paper’s interim report for the first quarter 2024 will be published on Thursday 25 April 2024 at about 07.30 CEST.Nordic Paper’s CEO Anita Sjölander and CFO Niclas Eriksson will present the report via an audiocasted telephone conference on the same day at 9.30 CEST. The presentation will be held in English and will be followed by a Q&A session. The presentation can be followed on: https://fronto.vancastvideo.com/event/AxbFqVd0/9617/?lang=8864 To participate via telephone and thereby be able to ask questions, please register on the following link: https://services.

Report from Annual General Meeting 2024 of Cereno Scientific AB

Today, April 16, 2024. Cereno Scientific AB (publ) held Annual General Meeting at the MAQS Advokatbyrå’s premises at Östra Hamngatan 24 in Gothenburg, Sweden. Chairman of the Annual General Meeting (the “AGM”) was Fredrik Brusberg, associate at MAQS Advokatbyrå. The following main resolutions were resolved upon at the AGM: Adoption of income statement and balance sheet for the company and the group The AGM resolved to adopt the presented income statement and balance sheet for the company and the group. Allocation of result The AGM resolved, in accordance with the Board of

Assemblin’s Annual and Sustainability Report for 2023 is now published

The public Annual and Sustainability Report describes Assemblin´s operations, strategy and performance for the fiscal year 2023, and is now available as a digital version at our webpage.Besides the legal Annual Report the publication includes a sustainability report as well as a corporate governance report. The report is published in Swedish and English at our webpage at: English version: https://www.assemblin.com/investors/financial-reports/ Swedish version: https://www.assemblin.com/sv/investerare/finansiella-rapporter/ The Annual Report is also available as a printed version

Nimlas Group is growing rapidly and is now the fourth largest installation group in the Nordics

Nimlas Group is growing rapidly and is now the fourth largest installation group in the NordicsNimlas Group grew significantly during 2023. The acquisition of the Norwegian group Konstel laid the foundation for a new Nordic platform in the installation industry. In Nimlas' existing markets, the expansion continued with several acquisitions in electrical operations in Sweden and a number of service-oriented companies in Finland. In Norway, the expansion within the electrical segment continued. In 2023, Nimlas achieved a pro forma turnover of SEK 8 billion, and the ambition is to continue

Form 8.3 - Mondi Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------------------+-----------------+|(a) Full name of discloser: |Ninety One UK Ltd|+----------------------------------------------------------+-----------------+|(b) Owner or controller of interests and short positions |  ||disclosed, if different from 1(a):

SOFTSWISS Invests in Largest European Social Casino

SOFTSWISS, a global tech expert with over 15 years of experience in iGaming, acquired a significant stake in Ously Games GmbH, the driving force behind the fastest-growing European social casino SpinArena.net.As a result of these investments, SOFTSWISS partnered with the German enterprise Ously Games GmbH to develop a new comprehensive software solution  for social casinos, aligning with recent iGaming industry trends. Social casinos, a fast-developing trend in online entertainment, offer a unique

Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc

Company release Nanoform Finland Plc April 16, 2024 13.50 Finnish time / 12.50 Swedish time Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc Nanoform Finland Plc’s (the “Company” or “Nanoform“) Board of Directors held its constitutive meeting on April 16, 2024. The meeting elected the following persons to the Audit and Compensation Committee of the Board of Directors of the Company: Miguel Calado (chairperson), Jeanne Thoma (ordinary member) and Mads Laustsen (ordinary member). The Audit and Compensation Committee is a permanent

Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024

Company release Nanoform Finland Plc April 16, 2024 13.40 Finnish time / 12.40 Swedish time Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024 Nanoform Finland Plc (the “Company” or “Nanoform“) held its Annual General Meeting for 2024 on April 16, 2024 at the Company's head office in Helsinki, Finland. 46 shareholders representing 47 689 036 shares and votes were represented at the meeting (60.79% of all outstanding shares and votes). The Annual General Meeting supported all the Board of Directors' proposals. The Annual General Meeting approved

Regulatory application in China receives "Notice of Acceptance" status

VibroSense Chinese distributor UMCARE, announces that it has received a so-called "Notice of Acceptance" from the Chinese authority NMPA, regarding the company's application for regulatory approval in China for VibroSense Meter ® II and Diabetic Foot Screening.In a next step, a "Supplementary Notice" is expected to be received from the NMPA during June 2024. Thereafter, the application enters the final stage which includes final supplements before a certificate can be issued by the NMPA, which is expected to be ready in December 2024. The new timetable, which was communicated on March 12,

Salsa Technology is Primed to Showcase its Localised LatAm Solutions at BIS SiGMA Americas

Salsa Technology is pleased to reveal that it will showcase its localised LatAm solutions at the significant BIS SiGMA Americas. The iGaming event is being held in Brazil, São Paulo, at Transamerica Expo, from April 23rd to 24th.Exhibiting at BIS SiGMA Americas gives Salsa the prime opportunity to promote its cutting-edge technology and highly-flexible solutions created specifically to meet the needs of local markets. Salsa’s expert team will be stationed from stand #M51 where they will be available to talk in-depth about its suite products and solutions. The GLI-certified PAM, Salsa Omni,

With Future in Mind: Launching Your iGaming Venture in 2024

The digital landscape of gambling entertainment offers immense opportunities, guided by competition and regulatory challenges. With the consideration of the freshest trends, technological requirements, and strategic approaches, a profitable venture can become a real project in almost no time.With proper support from assistant companies and adherence to the streamlined procedure of site elaboration, any entrepreneur can become an iGaming platform owner. 2WinPower casino software  is an excellent choice for the foundation of a profitable gambling venture. iGaming

Akastor ASA: Minutes of Annual General Meeting 2024

The Annual General Meeting of Akastor ASA (OSE: AKAST) was held on Tuesday 16 April 2024. The meeting was held as a digital meeting.All proposals on the agenda were adopted, cf. updated Notice of Annual General Meeting attached to the stock exchange release dated 25 March 2024.The general meeting elected three shareholder-appointed directors to the board. Frank O. Reite, Lone Fønss Schrøder and Svein Oskar Stoknes are re-elected as directors for a term of two-years. The board of directors now comprises of:Frank Reite (chairperson)Lone Fønss Schrøder (deputy chairperson)Svein

Oterra welcomes Hubert Windegger as new Chief Financial Officer

Today we announce a new incoming Chief Financial Officer, Hubert Windegger, who will join Oterra effective April 22nd, 2024.Hubert Windegger joins us with over 14 years of finance leadership experience, including roles at Private Equity-owned carve-outs and as CFO of ASK Chemicals. His strategic insights and proven track record in driving growth make him an invaluable addition to Oterra as we continue to innovate and expand our reach in the natural color ingredients markets.  This change comes from Oterra's current CFO, Mads Dehlsen Winther, who, after careful consideration, has decided

P CAPITAL PARTNERS IV ISSUES NEW DEBENTURES

PRESS RELEASEStockholm, 16 April 2024 P Capital Partners IV AB (publ) today announces that on 30 April 2024, the company will increase its contributed capital by EUR 15,2 million through the issuance of 192,800 series A1 participation loan debentures at a price of EUR 79 each and by EUR 0.06 million through an equity contribution. The new debentures will be eligible for coupon payments from the third quarter 2024. Including the newly issued debentures, P Capital Partners IV’s funding amounts to EUR 347,7 million comprised of series A1 participation loan debentures of EUR 346,5

Valmet to deliver a boiler rebuild to E.ON’s power station in Scotland, the United Kingdom

Valmet Oyj’s press release on April 16, 2024 at 1:00 p.m. EESTValmet will deliver a major boiler rebuild to E.ON’s Steven’s Croft biomass power station in Lockerbie, Scotland in the United Kingdom to secure trouble-free operation of the boiler for years to come. The order is included in Valmet’s orders received of the first quarter 2024. The value of the order will not be disclosed. The scheduled delivery period will be during the second quarter of 2024. Steven’s Croft’s bubbling fluidized bed (BFB) boiler, originally delivered by Valmet, was started up in 2008. With good day-to-day

RESURGENCE: Aquaporin joins project for innovative water treatment solutions

Twenty partners from 11 countries have joined forces to work on water treatment in the pulp & paper, chemical, and steel sectors, and herein exploring synergies between urban water treatment and industrial operations through innovative solutions through the EU-funded RESURGENCE project.With a comprehensive approach integrating efficient technologies and digital solutions for water circularity, energy, and feedstock recovery for EU process industries, RESURGENCE aims to significantly contribute to EU climate neutrality, circularity, and competitiveness.  At Aquaporin, the project will be

Paindrainer AB to be granted patent for its unique patient-centric concept for chronic pain management

MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB, a pioneer in the field of digital healthcare technology, is pleased to announce that the European Patent Office (EPO) has granted a patent for its unique proprietary platform for 360° patient-centricity, chronic pain management, powered by an artificial neural network.At its core, this patent outlines a personalized pain-management platform that leverages users’ own data and a neural network analysis to provide tailored recommendations. These recommendations are fully adaptive to each user, aiming to alleviate pain and enhance quality of life

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 88 – 16 APRIL 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Fortum will publish its January−March 2024 Interim Report on 30 April 2024

FORTUM CORPORATION INVESTOR NEWS 16 APRIL 2024 AT 11:30 EEST Fortum's January−March 2024 Interim Report will be published on 30 April 2024 at approximately 9:00 EEST. A combined live webcast/teleconference for media, investors, and analysts will be arranged online on the same day at 11:00 EEST. For the webcast, use the link at www.fortum.com/investors. To ask questions, please join the teleconference by registering using the following link: https://palvelu.flik.fi/teleconference/?id=50047355 

There are no items matching the current filter
There are no more items matching the current filter
Back to top